Zydus Lifesciences informs about press release

17 Feb 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated February 17, 2023 titled ‘Zydus receives final approval from the USFDA for Sirolimus Tablets, 1 mg and 2 mg’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

917.45 -10.65 (-1.15%)
24-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1737.50
Dr. Reddys Lab 1266.35
Cipla 1496.35
Zydus Lifesciences 917.45
Lupin 2109.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×